Bactericidal activity of Myrrh extracts and two dosage forms against standard bacterial strains and multidrug-resistant clinical isolates with GC/MS profiling

被引:22
|
作者
Khalil, Noha [1 ]
Fikry, Sahar [2 ]
Salama, Osama [1 ]
机构
[1] Future Univ Egypt, Fac Pharmaceut Sci & Pharmaceut Ind, Cairo 11835, Egypt
[2] Pharos Univ Alexandria, Fac Appl Hlth Sci Technol, Alexandria 21311, Egypt
关键词
Essential oil; S; aureus; Ps; aeruginosa; Myrrh cream; Myrrh mouthwash; Multi-resistant clinical isolates; COMMIPHORA-MOLMOL; ESSENTIAL OIL; ANTIBACTERIAL; FRANKINCENSE; TERPENES; RESIN;
D O I
10.1186/s13568-020-0958-3
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Myrrh is the resinous exudate obtained by the incision in Commiphora molmol trees (Family Burseraceae). The bactericidal activity of its hexane extract was compared to its essential oil (MEO) using viable count technique against Staphylococcus aureus (S. aureus) and Pseudomonas aeruginosa (Ps. aeruginosa). MEO exhibited a better activity with > 99.999% killing of both tested strains after 2 h contact time. MEO was tested using the same technique against four multidrug resistant isolates: S. aureus (MRSA, sputum), Escherichia coli (E. coli, urine), Ps. aeruginosa (wound) and Klebsiella pneumonia (K. pneumonia, sputum). Highest bactericidal activity was observed against Ps. aeruginosa while lowest was against K. pneumonia (99.59 and 54.04% killing, respectively after 2 h contact time). A cream and mouthwash were formulated using 5% v/v MEO. The cream showed a better activity against Ps. aeruginosa than S. aureus (95.11 and 86.76% killing, respectively after 2 h contact time). The in vitro treatment of ca 10(7) CFU/ml S. aureus cells suspended in 10% saliva with the mouthwash produced ca 46% killing within the first 15 min reaching ca 99.999% after 30 min. Cytotoxic studies of both the essential oil and hexane extract on human liver cancer (Hep G2), human breast cancer (MCF-7) and colon cancer cell lines (HCT-116) revealed a promising in vitro activity. Highest activity was recorded for the essential oil on MCF-7 with IC50 10.93 +/- 0.32 mu g/ml. GC/MS analysis allowed the identification of 17 and 9 compounds representing 92.01 and 99.99% of the hexane extract and essential oil, respectively. Furano-eudesma-1,3-diene (15.99%) and 2-acetoxy-furano-diene (26.82%) were the major identified compounds in the hexane extract and essential oil, respectively. These results indicate that Myrrh essential oil is a promising antibacterial and cytotoxic agent that can be formulated in suitable dosage forms.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] In Vitro Synergistic Activity of Colistin and Ceftazidime or Ciprofloxacin Against Multidrug-Resistant Clinical Strains of Pseudomonas aeruginosa
    D'Souza, Beena Benita
    Padmaraj, Sunil Rao
    Rekha, Panchapaddy Devasya
    Tellis, Rouchelle Charmaine
    Prabhu, Sudharshan
    Pothen, Priyanka
    MICROBIAL DRUG RESISTANCE, 2014, 20 (06) : 550 - 554
  • [42] In Vitro Activity of Pentamidine Alone and in Combination with Antibiotics against Multidrug-Resistant Clinical Pseudomonas aeruginosa Strains
    Herrera-Espejo, Soraya
    Cebrero-Cangueiro, Tania
    Labrador-Herrera, Gema
    Pachon, Jeronimo
    Eugenia Pachon-Ibanez, Maria
    Alvarez-Marin, Rocio
    ANTIBIOTICS-BASEL, 2020, 9 (12): : 1 - 11
  • [43] Study of the antimicrobial activity of cationic carbosilane dendrimers against clinical strains of multidrug-resistant bacteria and their biofilms
    Hernando-Gozalo, Marcos
    Aguilera-Correa, John Jairo
    Rescalvo-Casas, Carlos
    Seijas-Pereda, Laura
    Garcia-Bertolin, Carlos
    de la Mata, Francisco Javier
    Sanchez-Nieves, Javier
    Cuadros, Juan
    Perez-Tanoira, Ramon
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [44] Mutant Prevention Concentration of Ciprofloxacin against Klebsiella pneumoniae Clinical Isolates: An Ideal Prognosticator in Treating Multidrug-Resistant Strains
    Priyadarshini, B. Aditi
    Mahalakshmi, Krishnan
    Kumar, Venkatesan Naveen
    INTERNATIONAL JOURNAL OF MICROBIOLOGY, 2019, 2019
  • [45] In vitro activity of tetracycline analogs against multidrug-resistant and extensive drug resistance clinical isolates of Mycobacterium tuberculosis
    Zhang, Chi
    Ouyang, Qi
    Zhou, Xianyuan
    Huang, Yingfeng
    Zeng, Yu
    Deng, Li
    Lin, Dachuan
    Zheng, Weidong
    TUBERCULOSIS, 2023, 140
  • [46] Novel oxazolidinones harbor potent in vitro activity against the clinical isolates of multidrug-resistant Mycobacterium tuberculosis in China
    Wang, Chenqian
    Wang, Guirong
    Huo, Fengmin
    Xue, Yi
    Jia, Junnan
    Dong, Lingling
    Zhao, Liping
    Wang, Fen
    Huang, Hairong
    Duan, Hongfei
    FRONTIERS IN MEDICINE, 2022, 9
  • [47] Antibacterial activity of green synthesized silver nanoparticles using Pistacia hull against multidrug-resistant clinical isolates
    Nokhodian, Zary
    Mousavi-Khattat, Mohammad
    Gharibi, Shima
    Rostami, Soodabeh
    Zeraati, Parisa
    Rahimmalek, Mehdi
    Szumny, Antoni
    NANOMEDICINE JOURNAL, 2024, 11 (04) : 450 - 457
  • [48] Activity of solvent extracts of Prosopis spicigera, Zingiber officinale and Trachyspermum ammi against multidrug resistant bacterial and fungal strains
    Khan, Rosina
    Zakir, Mohammad
    Afaq, Sadul H.
    Latif, Abdul
    Khan, Asad U.
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2010, 4 (05): : 292 - 300
  • [49] An Endolysin LysSE24 by Bacteriophage LPSE1 Confers Specific Bactericidal Activity against Multidrug-Resistant Salmonella Strains
    Ding, Yifeng
    Zhang, Yu
    Huang, Chenxi
    Wang, Jia
    Wang, Xiaohong
    MICROORGANISMS, 2020, 8 (05)
  • [50] BIOACTIVE COMPOUNDS FROM ROSMARINUS OFFICINALIS AGAINST MULTIDRUG-RESISTANT CLINICAL STRAINS OF STAPHYLOCOCCUS AUREUS: IN VITRO ACTIVITY
    Caceres Guido, P.
    Ojeda Sans, A.
    Blanco, A.
    Lopardo, H.
    Macchi, A.
    van Baren, C.
    Dell'Orso, M.
    Moreno, S.
    PEDIATRIC RESEARCH, 2012, 72 (01) : 109 - 109